China Pharma Holdings
CPHI
8 hedge funds and large institutions have $534K invested in China Pharma Holdings in 2020 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 0 closing their positions.
60% more funds holding
Funds holding: 5 → 8 (+3)
16% more capital invested
Capital invested by funds: $460K → $534K (+$74K)
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| 1 |
VF
Virtu Financial
New York
|
+$31.6K |
| 2 |
Renaissance Technologies
New York
|
+$28.2K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$14.8K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$6.02K |
Top Sellers
| 1 |
HF
HRT Financial
New York
|
-$56.7K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$37.2K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$12.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $354K | +$28.2K | +131 | +9% |
|
|
BCM
2
Bridgeway Capital Management
Houston,
Texas
| $105K | – | – | – |
|
|
VF
3
Virtu Financial
New York
| $33K | +$31.6K | +147 | New |
|
|
TSS
4
Two Sigma Securities
New York
| $15K | +$14.8K | +69 | New |
|
|
HF
5
HRT Financial
New York
| $8K | -$56.7K | -264 | -88% |
|
|
6
UBS Group
Zurich,
Switzerland
| $8K | -$12.5K | -58 | -60% |
|
|
7
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $6K | +$6.02K | +28 | New |
|
|
8
Citadel Advisors
Miami,
Florida
| $5K | -$37.2K | -173 | -88% |
|
CPHI Hedge Fund Activity: Q4 2020 in Review
8 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q4 2020, worth a combined $534K — up 16% from $460K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CPHI positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 3 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $31.6K. The largest seller was HRT Financial, cutting an estimated $56.7K.
- 8 institutional investors held China Pharma Holdings (CPHI) as of Q4 2020, up from 5 in Q3 2020.
- Funds reported $534K of China Pharma Holdings stock for Q4 2020, up 16% quarter-over-quarter.
- 3 funds opened new China Pharma Holdings positions in Q4 2020 and 0 closed out, a net change of +3 holders.
- The largest China Pharma Holdings buyer in Q4 2020 was Virtu Financial, an estimated $31.6K added.
- The largest China Pharma Holdings seller in Q4 2020 was HRT Financial, an estimated $56.7K sold.
Based on aggregated 13F filings for Q4 2020.